They are in contrast to a mouse study recently published by Kautz et al. [49], which indicated that increased macrophage iron as a result of a loss-of-function ferroportin mutation, mimicking the effect of increased hepcidin concentration, does not promote atherosclerosis. The gene discussed is SLC40A1; the disease is atherosclerosis.